1. Home
  2. ADXN vs ULY Comparison

ADXN vs ULY Comparison

Compare ADXN & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • ULY
  • Stock Information
  • Founded
  • ADXN 2002
  • ULY 2013
  • Country
  • ADXN Switzerland
  • ULY United States
  • Employees
  • ADXN N/A
  • ULY N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • ADXN Health Care
  • ULY
  • Exchange
  • ADXN Nasdaq
  • ULY Nasdaq
  • Market Cap
  • ADXN 8.5M
  • ULY 5.8M
  • IPO Year
  • ADXN N/A
  • ULY N/A
  • Fundamental
  • Price
  • ADXN $10.95
  • ULY $2.89
  • Analyst Decision
  • ADXN
  • ULY Strong Buy
  • Analyst Count
  • ADXN 0
  • ULY 2
  • Target Price
  • ADXN N/A
  • ULY $11.50
  • AVG Volume (30 Days)
  • ADXN 6.8K
  • ULY 995.2K
  • Earning Date
  • ADXN 11-21-2025
  • ULY 11-11-2025
  • Dividend Yield
  • ADXN N/A
  • ULY N/A
  • EPS Growth
  • ADXN N/A
  • ULY N/A
  • EPS
  • ADXN N/A
  • ULY N/A
  • Revenue
  • ADXN $210,347.00
  • ULY $131,235,000.00
  • Revenue This Year
  • ADXN $86.57
  • ULY N/A
  • Revenue Next Year
  • ADXN N/A
  • ULY $20.23
  • P/E Ratio
  • ADXN N/A
  • ULY N/A
  • Revenue Growth
  • ADXN N/A
  • ULY N/A
  • 52 Week Low
  • ADXN $6.51
  • ULY $2.75
  • 52 Week High
  • ADXN $12.05
  • ULY $17.99
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 62.51
  • ULY 34.72
  • Support Level
  • ADXN $8.53
  • ULY $3.01
  • Resistance Level
  • ADXN $9.51
  • ULY $3.43
  • Average True Range (ATR)
  • ADXN 0.74
  • ULY 0.48
  • MACD
  • ADXN 0.05
  • ULY 0.02
  • Stochastic Oscillator
  • ADXN 71.51
  • ULY 5.25

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: